Page last updated: 2024-10-26

disopyramide and Tachyarrhythmia

disopyramide has been researched along with Tachyarrhythmia in 141 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Research Excerpts

ExcerptRelevanceReference
"The role of provocation tests for the assessment of amiodarone therapy in patients with ventricular tachycardia remains a subject of controversy: recent studies seem to show that the ability to initiate VT in patients on amiodarone is compatible with a good long-term result."9.05[Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. ( Bounhoure, JP; Calazel, J; Cassagneau, B; Fauvel, JM; Marin, T; Massabuau, P; Narula, OS; Puel, J; Tournadre, P, 1984)
"Disopyramide (B 712) was tested in 39 patients with chronic arrhythmias of different kind: 23 cases with atrial fibrillation, 16 cases with ventricular ectopic beats, two cases with supraventricular tachycardias."9.04[Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation]. ( Breithardt, G; Haerten, K; Seipel, L, 1976)
"Patients with acute myocardial infarction admitted to open wards of three hospitals were given either oral disopyramide (100 mg four times daily) or matching placebo, prophylactically, for seven days."9.04Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. ( Besterman, EM; Carmichael, DJ; Gillham, AD; Griffiths, JW; Kidner, PH; Summers, GD; Zainal, N, 1977)
"The effects of intravenously administered disopyramide phosphate were evaluated in seven patients with refractory ventricular tachycardia."9.04Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. ( Mason, DT; Miller, RR; Vera, Z; Vismara, LA, 1977)
"Methoxamine, an alpha adrenoreceptor agonist, and sleep abolished repetitive nonsustained monomorphic ventricular tachycardia in a 41-year-old man without detectable underlying heart disease."7.68Repetitive nonsustained monomorphic ventricular tachycardia aborted by methoxamine and sleep "heart rate dependent ventricular tachycardia". ( Ohe, T; Shimomura, K; Takagaki, K, 1991)
"The purpose of our study was to assess the efficacy of Propafenon in comparison with Disopyramide in the long-term treatment of repetitive ventricular tachycardia."7.67[Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. ( Bomba, E; Bracchetti, D; Capucci, A; Lombardi, G; Naccarella, F; Palmieri, M, 1984)
"A study of the efficacy of intravenous disopyramide in the conversion of supraventricular tachyarrhythmias to sinus rhythm was undertaken in a group of 23 patients with a variety of cardiological diagnoses."7.67The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias. ( Ikram, H; Stewart, DE, 1984)
"Intraindividual comparison of the acute response to intravenous quinidine and to intravenous disopyramide was performed in 27 patients with sustained ventricular tachycardia (VT) who underwent serial electrophysiological studies."7.67Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia. ( Brachmann, J; Kübler, W; Lengfelder, W; Rizos, I; Schmitt, C; Senges, J; von Olshausen, K, 1987)
"A 44-year-old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia (AVT, torsade de pointes)."7.66Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide. ( Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D, 1982)
"A 59-year-old man presented with atrial flutter and a 2:1 atrioventricular response, which, after intravenous disopyramide, became 1:1."7.66Extreme tachycardia complicating the use of disopyramide in atrial flutter. ( Miller, HC; Robertson, CE, 1980)
"We evaluated 126 patients with inducible sustained ventricular tachyarrhythmias to assess whether the response to procainamide during electrophysiologic study could predict responses to other conventional antiarrhythmic agents and combinations of agents."7.66The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. ( Buxton, AE; Josephson, ME; Sadowski, LM; Waxman, HL, 1983)
"A patient with ischemic cardiomyopathy and congestive heart failure was treated with disopyramide phosphate for ventricular arrhythmias."7.66Disopyramide-induced ventricular tachycardia. ( Gantz, KB; Lo, KS; Lucchesi, BR; Pitt, B; Stetson, PL, 1980)
"The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure."7.66Efficacy of intravenous disopyramide in acute cardiac arrhythmias. ( De Backer, M; Kahn, RJ; Stoupel, E, 1981)
"Two cases of documented torsade de pointes ventricular tachycardia in association with the use of disopyramide are described."7.66Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine. ( Colman, JM; Wald, RW; Waxman, MB, 1981)
"Oral antiarrhythmic treatment with mexiletine and disopyramide was evaluated in 34 patients with recurrent sustained ventricular tachycardias by programmed ventricular stimulation, except in a few instances where spontaneous attacks occurred under therapy."7.66Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation. ( Lüderitz, B; Manz, M; Nitsch, J; Steinbeck, G, 1983)
"In a 41-year-old male with diabetes mellitus well controlled with insulin (50 units/day), hypoglycemia developed after starting disopyramide treatment (200 mg/day) for correction of tachycardia."7.66Hypoglycemic effect of disopyramide in a case of diabetes mellitus under insulin treatment. ( Taketa, K; Yamamoto, Y, 1980)
"Two patients with atrial arrhythmias are described who developed ventricular tachyarrhythmias shortly after starting disopyramide therapy."7.66Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs. ( Croft, CH; Kennelly, BM, 1981)
"The electrophysiologic actions of disopyramide phosphate on reentrant ventricular tachycardia induced by premature ventricular stimuli were evaluated in conscious dogs 2 to 4 days after myocardial infarction."7.66Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. ( Gibson, JK; Lucchesi, BR; Patterson, E, 1980)
"The efficacy of disopyramide in the management of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) was evaluated in 50 patients by programmed ventricular stimulation: 38 patients had coronary artery disease (16 with left ventricular aneurysm), 8 had other cardiac diseases, and 4 had no apparent heart disease."7.66Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. ( Buxton, AE; Josephson, ME; Lerman, BB; Waxman, HL, 1983)
"The oral administration of disopyramide for the maintenance of sinus rhythm after cardioversion from atrial fibrillation resulted in prolongation of the Q-T interval and three episodes of ventricular tachycardia with the torsade de pointes morphology."7.66Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide. ( Beck, W; Commerford, PJ, 1980)
"By means of intracardiac recordings and programmed electrical stimulation of the heart, the combination effect of verapamil and disopyramide on induction of circus movement tachycardia was studied in 8 patients with anomalous extranodal atrioventricular (A-V) pathway."7.66Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation. ( Kawai, C; Konishi, T; Matsuda, H; Matsuyama, E; Tamamura, T, 1981)
"We evaluated the electrophysiologic effects of disopyramide phosphate in 12 patients with the Wolff-Parkinson-White syndrome."7.66Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. ( Cook, L; Gallagher, JJ; Kerr, CR; Prystowsky, EN; Smith, WM, 1982)
"A patient presenting with atypical ventricular tachycardia due to oral disopyramide given in normal doses over a period of four months is described."7.66Disopyramide induced atypical ventricular tachycardia. ( Chia, BL, 1980)
"We performed electrophysiologic studies before and after oral administration of disopyramide phosphate, 200 mg every 6 hours, in 20 patients with atrioventricular (AV) reentrant tachycardia using a retrogradely conducting accessory pathway."7.66Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction. ( Hung, JS; Kou, HC; Lee, YS; Wu, D, 1982)
"An unusual ventricular tachyarrhythmia developed in a 57 year old woman with recurrent ventricular tachycardia and toxic disopyramide plasma concentrations."7.66Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. ( Martin, RP; McMorrow, M; Meltzer, RS; Robert, EW, 1978)
"The probability of absence of recurrence at 6 months was 36 +/- 11% in Group C and 55 +/- 10% in Group D (p = NS)."6.69[A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. ( Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O, 1998)
"Propafenone also showed a lower incidence of side effects."6.66Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study. ( Ambrosioni, E; Bertaccini, P; Bracchetti, D; Cantelli, I; Naccarella, F; Palmieri, M, 1985)
"Out of the 28 severe arrhythmias studied, it was the ventricular extrasystoles which benefited most from treatment (79% completely successful, while there was a lesser degree of success in treating the ventricular tachycardias (35% completely successful, 30% partially successful)."6.64[Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction]. ( Bellanger, P; Desoutter, P; Motté, G; Vogel, M; Welti, JJ, 1976)
"Disopyramide has a selective effect on potential reentry circuits in ischemic myocardium, and prolongs refractoriness in abnormal myocardium to a greater extent than its effect on the normal ventricle."5.27Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase. ( Brachmann, J; Cobbe, SM; Hoffmann, E; Kübler, W; Ritzenhoff, A; Senges, J, 1984)
"The arrhythmia started with an atrial extrasystole arising well outside the functional refractory period of the AV node, and it could be reproduced by inflation of a balloon."5.26Ectopic atrial tachycardia on swallowing. Report on favourable effect of verapamil. ( Landmark, K; Storstein, O, 1979)
"The relative safety and efficacy of intravenous administration of adenosine, lignocaine, disopyramide, flecainide, and sotalol for termination of stable, induced ventricular tachycardia was assessed in serial trials."5.06Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. ( Camm, AJ; Garratt, CJ; Griffith, MJ; Linker, NJ; Ward, DE, 1990)
"Oral long-term treatment with various antiarrhythmic drugs (aprindine, mexiletine, disopyramide, amiodarone) was assessed in 82 patients with recurrent tachycardias demonstrated in the ECG using programmed ventricular stimulation."5.05[Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?]. ( Lüderitz, B; Manz, M; Steinbeck, G, 1983)
"The role of provocation tests for the assessment of amiodarone therapy in patients with ventricular tachycardia remains a subject of controversy: recent studies seem to show that the ability to initiate VT in patients on amiodarone is compatible with a good long-term result."5.05[Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. ( Bounhoure, JP; Calazel, J; Cassagneau, B; Fauvel, JM; Marin, T; Massabuau, P; Narula, OS; Puel, J; Tournadre, P, 1984)
"Disopyramide (B 712) was tested in 39 patients with chronic arrhythmias of different kind: 23 cases with atrial fibrillation, 16 cases with ventricular ectopic beats, two cases with supraventricular tachycardias."5.04[Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation]. ( Breithardt, G; Haerten, K; Seipel, L, 1976)
"Patients with acute myocardial infarction admitted to open wards of three hospitals were given either oral disopyramide (100 mg four times daily) or matching placebo, prophylactically, for seven days."5.04Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. ( Besterman, EM; Carmichael, DJ; Gillham, AD; Griffiths, JW; Kidner, PH; Summers, GD; Zainal, N, 1977)
"The effects of intravenously administered disopyramide phosphate were evaluated in seven patients with refractory ventricular tachycardia."5.04Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. ( Mason, DT; Miller, RR; Vera, Z; Vismara, LA, 1977)
" 2) When reversion is unsuccessful and ventricular response cannot be controlled with conventional therapy, rapid supraventricular tachyarrhythmias will often normalize in response to intravenous verapamil therapy, a calcium-blocking agent soon available for clinical use."4.76Intravenous antiarrhythmic drugs: newer aspects of therapy. ( Abbott, JA, 1982)
"Since disopyramide was introduced 5 years ago, the therapeutic spectrum of this drug in treating patients with ventricular and atrial arrhythmias has been found to be similar to that of the other type I antiarrhythmic drugs, quinidine and procainamide."4.76Disopyramide. ( Desai, J; Morady, F; Scheinman, MM, 1982)
"Methoxamine, an alpha adrenoreceptor agonist, and sleep abolished repetitive nonsustained monomorphic ventricular tachycardia in a 41-year-old man without detectable underlying heart disease."3.68Repetitive nonsustained monomorphic ventricular tachycardia aborted by methoxamine and sleep "heart rate dependent ventricular tachycardia". ( Ohe, T; Shimomura, K; Takagaki, K, 1991)
"A study of the efficacy of intravenous disopyramide in the conversion of supraventricular tachyarrhythmias to sinus rhythm was undertaken in a group of 23 patients with a variety of cardiological diagnoses."3.67The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias. ( Ikram, H; Stewart, DE, 1984)
"The purpose of our study was to assess the efficacy of Propafenon in comparison with Disopyramide in the long-term treatment of repetitive ventricular tachycardia."3.67[Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia]. ( Bomba, E; Bracchetti, D; Capucci, A; Lombardi, G; Naccarella, F; Palmieri, M, 1984)
" Sustained rapid ventricular tachyarrhythmias requiring cardioversion for termination were induced by double right ventricular apical extrastimuli during control, and treatment with disopyramide, quinidine, and fluocortolone."3.67Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. ( Belhassen, B; Laniado, S; Pines, A, 1989)
"The efficacy of mexiletine used alone, and in combination with a class Ia antiarrhythmic drug, was assessed in 159 previously drug-refractory patients with ventricular tachycardia (VT) during serial electrophysiologic studies and during long-term (5-year) clinical follow-up."3.67Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias. ( Garan, H; McElroy, M; McGovern, B; Newell, JB; Ruskin, JN; Schoenfeld, MH; Whitford, EG, 1988)
"Intraindividual comparison of the acute response to intravenous quinidine and to intravenous disopyramide was performed in 27 patients with sustained ventricular tachycardia (VT) who underwent serial electrophysiological studies."3.67Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia. ( Brachmann, J; Kübler, W; Lengfelder, W; Rizos, I; Schmitt, C; Senges, J; von Olshausen, K, 1987)
"A 59-year-old man presented with atrial flutter and a 2:1 atrioventricular response, which, after intravenous disopyramide, became 1:1."3.66Extreme tachycardia complicating the use of disopyramide in atrial flutter. ( Miller, HC; Robertson, CE, 1980)
"In a 41-year-old male with diabetes mellitus well controlled with insulin (50 units/day), hypoglycemia developed after starting disopyramide treatment (200 mg/day) for correction of tachycardia."3.66Hypoglycemic effect of disopyramide in a case of diabetes mellitus under insulin treatment. ( Taketa, K; Yamamoto, Y, 1980)
"A patient with ischemic cardiomyopathy and congestive heart failure was treated with disopyramide phosphate for ventricular arrhythmias."3.66Disopyramide-induced ventricular tachycardia. ( Gantz, KB; Lo, KS; Lucchesi, BR; Pitt, B; Stetson, PL, 1980)
"The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure."3.66Efficacy of intravenous disopyramide in acute cardiac arrhythmias. ( De Backer, M; Kahn, RJ; Stoupel, E, 1981)
"We performed electrophysiologic studies before and after oral administration of disopyramide phosphate, 200 mg every 6 hours, in 20 patients with atrioventricular (AV) reentrant tachycardia using a retrogradely conducting accessory pathway."3.66Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction. ( Hung, JS; Kou, HC; Lee, YS; Wu, D, 1982)
", verapamil, disopyramide, and procainamide, on paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (Af) and atrial flutter (AF) were evaluated electrophysiologically."3.66Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias. ( Hiejima, K; Satake, S; Suzuki, F; Takahashi, M, 1983)
"The efficacy of disopyramide in the management of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) was evaluated in 50 patients by programmed ventricular stimulation: 38 patients had coronary artery disease (16 with left ventricular aneurysm), 8 had other cardiac diseases, and 4 had no apparent heart disease."3.66Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation. ( Buxton, AE; Josephson, ME; Lerman, BB; Waxman, HL, 1983)
"Oral antiarrhythmic treatment with mexiletine and disopyramide was evaluated in 34 patients with recurrent sustained ventricular tachycardias by programmed ventricular stimulation, except in a few instances where spontaneous attacks occurred under therapy."3.66Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation. ( Lüderitz, B; Manz, M; Nitsch, J; Steinbeck, G, 1983)
"We evaluated 126 patients with inducible sustained ventricular tachyarrhythmias to assess whether the response to procainamide during electrophysiologic study could predict responses to other conventional antiarrhythmic agents and combinations of agents."3.66The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. ( Buxton, AE; Josephson, ME; Sadowski, LM; Waxman, HL, 1983)
"A 44-year-old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia (AVT, torsade de pointes)."3.66Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide. ( Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D, 1982)
" disopyramide for a supraventricular tachycardia resulted in a more serious ventricular dysrhythmia giving hypotension and this probably contributed to the development of a myocardial infarction."3.66Adverse reaction to disopyramide. ( Dibble, JB; Webster, NR, 1979)
"An unusual ventricular tachyarrhythmia developed in a 57 year old woman with recurrent ventricular tachycardia and toxic disopyramide plasma concentrations."3.66Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. ( Martin, RP; McMorrow, M; Meltzer, RS; Robert, EW, 1978)
"Two patients with atrial arrhythmias are described who developed ventricular tachyarrhythmias shortly after starting disopyramide therapy."3.66Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs. ( Croft, CH; Kennelly, BM, 1981)
"A patient presenting with atypical ventricular tachycardia due to oral disopyramide given in normal doses over a period of four months is described."3.66Disopyramide induced atypical ventricular tachycardia. ( Chia, BL, 1980)
"Two cases of documented torsade de pointes ventricular tachycardia in association with the use of disopyramide are described."3.66Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine. ( Colman, JM; Wald, RW; Waxman, MB, 1981)
"We evaluated the electrophysiologic effects of disopyramide phosphate in 12 patients with the Wolff-Parkinson-White syndrome."3.66Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. ( Cook, L; Gallagher, JJ; Kerr, CR; Prystowsky, EN; Smith, WM, 1982)
" This arrhythmia was induced by quinidine or disopyramide therapy."3.66Ventricular pacing in atypical ventricular tachycardia. ( Benhorin, J; Corcos, P; Golhman, JM; Keren, A; Stern, S; Tzivoni, D, 1981)
"By means of intracardiac recordings and programmed electrical stimulation of the heart, the combination effect of verapamil and disopyramide on induction of circus movement tachycardia was studied in 8 patients with anomalous extranodal atrioventricular (A-V) pathway."3.66Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation. ( Kawai, C; Konishi, T; Matsuda, H; Matsuyama, E; Tamamura, T, 1981)
"The oral administration of disopyramide for the maintenance of sinus rhythm after cardioversion from atrial fibrillation resulted in prolongation of the Q-T interval and three episodes of ventricular tachycardia with the torsade de pointes morphology."3.66Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide. ( Beck, W; Commerford, PJ, 1980)
"A controlled multicenter study has been carried out in 46 patients with ventricular tachyarrhythmias to define the antiarrhythmic effect of disopyramide phosphate."3.66[Therapy of ventricular tachyarrhythmia with disopyramid phosphate]. ( Engel, U; Enrico, JF; Mattmann, H; Steinbrunn, W, 1980)
"The electrophysiologic actions of disopyramide phosphate on reentrant ventricular tachycardia induced by premature ventricular stimuli were evaluated in conscious dogs 2 to 4 days after myocardial infarction."3.66Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. ( Gibson, JK; Lucchesi, BR; Patterson, E, 1980)
"Disopyramide phosphate was administered intravenously to 57 patients with 60 episodes of arrhythmia (21 supraventricular and 39 ventricular) as a 2 mg/kg bolus."3.65The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. ( Deano, DA; Ehsani, AI; Mautner, RK; Rosen, KM; Sherman, RH; Wu, D, 1977)
"The probability of absence of recurrence at 6 months was 36 +/- 11% in Group C and 55 +/- 10% in Group D (p = NS)."2.69[A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. ( Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O, 1998)
"Propafenone also showed a lower incidence of side effects."2.66Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study. ( Ambrosioni, E; Bertaccini, P; Bracchetti, D; Cantelli, I; Naccarella, F; Palmieri, M, 1985)
"Out of the 28 severe arrhythmias studied, it was the ventricular extrasystoles which benefited most from treatment (79% completely successful, while there was a lesser degree of success in treating the ventricular tachycardias (35% completely successful, 30% partially successful)."2.64[Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction]. ( Bellanger, P; Desoutter, P; Motté, G; Vogel, M; Welti, JJ, 1976)
" Special consideration, however, must be given with regard to drug selection and dosage in order to avoid adverse effects on the mother and fetus."2.36Antiarrhythmic drug therapy during pregnancy. ( Elkayam, U; Frishman, W; Rotmensch, HH, 1983)
" The latter, however, was taking antiarrhythmic drugs at a dosage less than that proved to be effective during electropharmacological testing."1.27[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation]. ( Delise, P; Di Pede, F; Piccolo, E; Raviele, A, 1984)
"Disopyramide has a selective effect on potential reentry circuits in ischemic myocardium, and prolongs refractoriness in abnormal myocardium to a greater extent than its effect on the normal ventricle."1.27Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase. ( Brachmann, J; Cobbe, SM; Hoffmann, E; Kübler, W; Ritzenhoff, A; Senges, J, 1984)
" If side effects intervene that may cause continued therapy to be intolerable, changing the antiarrhythmic agent, as opposed to decreasing the dosage to an ineffective range, may be appropriate."1.27New directions in antiarrhythmic drug therapy. ( Somberg, JC, 1984)
"Mexiletine was combined with a conventional type IA antiarrhythmic agent in 25 patients (49%)."1.27Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias. ( Bardy, GH; Fahrenbruch, CE; Graham, EL; Greene, HL; Poole, JE; Pulaski, WP; Werner, JA, 1986)
"The arrhythmia started with an atrial extrasystole arising well outside the functional refractory period of the AV node, and it could be reproduced by inflation of a balloon."1.26Ectopic atrial tachycardia on swallowing. Report on favourable effect of verapamil. ( Landmark, K; Storstein, O, 1979)
"Disopyramide has the advantage of being available both as an oral and an intravenous preparation and is a useful drug to be added to the list of more conventional anti-dysrhythmic agents."1.26Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias. ( Green, AG, 1979)
"atrial premature beats (APBs) which were conducted to the ventricles normally or aberrantly; 2."1.26Atrial bigeminy with block associated with bradycardia and paroxysmal atrial fibrillation -- an important variant of the tachycardia-bradycardia syndrome. ( Camm, AJ; Spurrell, RA; Ward, DE; Washington, HG, 1979)

Research

Studies (141)

TimeframeStudies, this research(%)All Research%
pre-1990134 (95.04)18.7374
1990's7 (4.96)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rotmensch, HH1
Elkayam, U1
Frishman, W1
Prystowsky, EN4
Somberg, JC2
Kienzle, MG1
Williams, PD1
Zygmont, D1
Doherty, JU1
Josephson, ME6
Lo, KS1
Gantz, KB1
Stetson, PL1
Lucchesi, BR2
Pitt, B1
Theisen, K2
Jahrmärker, H1
Berman, ND1
De Backer, M1
Stoupel, E1
Kahn, RJ1
Zhivoderov, VM1
Zakharov, VN1
Doshchitsin, VL1
Aksenova, TN1
Andriukova, EI1
Garson, A1
Gillette, PC1
Lüderitz, B3
Levick, CE1
Mizgala, HF1
Kerr, CR2
Sevick, RJ1
Wyse, DG3
Manz, M2
Steinbeck, G2
Cassagneau, B1
Calazel, J1
Puel, J1
Massabuau, P1
Tournadre, P1
Fauvel, JM1
Bounhoure, JP1
Marin, T1
Narula, OS1
Taketa, K1
Yamamoto, Y1
Yamaguchi, A1
Kato, T1
Shimada, E1
Matsumoto, K1
Asano, H1
Yamane, Y1
Watanabe, M1
Palmieri, M2
Capucci, A1
Lombardi, G1
Naccarella, F2
Bomba, E1
Bracchetti, D2
Frucht, J1
Freimann, I1
Merin, S1
Raviele, A1
Di Pede, F1
Delise, P1
Piccolo, E1
Stewart, DE1
Ikram, H2
Cobbe, SM1
Hoffmann, E1
Ritzenhoff, A1
Brachmann, J2
Kübler, W2
Senges, J2
Romano, M1
Garbarini, U1
Cazzani, E1
Agre, K1
Komatsu, C1
Ishinaga, T1
Motoyama, M1
Marutani, K1
Teruya, H1
Nakayama, M1
Kuno, A1
Sato, Y1
Yoshimura, S1
Rinkenberger, RL1
Jackman, WM1
Naccarelli, GV1
Heger, JJ1
Zipes, DP1
Smith, WM1
Cook, L1
Gallagher, JJ2
Kou, HC1
Hung, JS1
Lee, YS1
Wu, D2
Kasanuki, H1
Ohnishi, S1
Hirosawa, K1
Yanaga, T1
Ichimaru, Y1
Ueno, T1
Hata, Y1
Okamoto, K1
Kodama, Y1
Otsuka, K1
Hiejima, K1
Suzuki, F1
Takahashi, M1
Satake, S1
Lerman, BB1
Waxman, HL2
Buxton, AE2
Nitsch, J1
Riccioni, N1
Castiglioni, M1
Bartolomei, C1
Sadowski, LM1
Koeda, T1
Ichikawa, T1
Kikuchi, H1
Chiba, S1
Matsushita, K1
Ozeki, T1
Sato, M1
Miura, S1
Saito, S1
Kawamura, A1
Yoshinaga, S1
Urabe, K1
Kawakami, M1
Orikasa, C1
Kato, M1
Neumann, G1
Grube, E1
Funke, H1
Chia, BL2
Breithardt, G3
Seipel, L3
Abendroth, RR1
Loogen, F1
Morady, F1
Scheinman, MM2
Desai, J1
Abbott, JA1
Keren, A4
Tzivoni, D4
Gottlieb, S3
Benhorin, J3
Stern, S4
Santinelli, V1
Chiariello, M1
Condorelli, M1
Welch, WJ1
Strasberg, B2
Coelho, A1
Rosen, KM3
Swiryn, S1
Bauernfeind, RA1
Palileo, E1
Iverson, N1
Levy, PS1
Feigl, D1
Ashkenazi, J1
Schwarzmann, H1
Croft, CH1
Kennelly, BM1
Wald, RW1
Waxman, MB1
Colman, JM1
Golhman, JM1
Corcos, P1
Gavish, D1
Levi, J1
Matsuda, H1
Konishi, T1
Matsuyama, E1
Tamamura, T1
Kawai, C1
Edhag, O1
Forssell, G1
Schenck-Gustafsson, K1
Sullivan, J1
Ee, B1
Oh, V1
Vajola, SF1
Chiavarelli, V1
Milazzotto, F1
Herling, IM1
Horowitz, LN4
Rothman, MT1
Porterfield, JG1
Antman, EM1
Lown, B1
Commerford, PJ1
Beck, W1
Lara, M1
Oakley, GD1
Rowbotham, D1
Steinbrunn, W1
Mattmann, H1
Enrico, JF1
Engel, U1
Vetter, VL1
Harken, AH1
Patterson, E1
Gibson, JK1
Robertson, CE1
Miller, HC1
Haerten, K2
Piot, O1
Flammang, D1
Dambrine, P1
Cheikel, J1
Jouannon, C1
Graux, P1
Baudouy, Y1
Bine-Scheck, F1
Leenhardt, A1
Donaldson, RM1
Nisbet, T1
Dreifus, LS1
Spurrell, RA3
Thorburn, CW1
Camm, J1
Sowton, E1
Deuchar, DC1
Vogel, M1
Desoutter, P1
Bellanger, P1
Motté, G1
Welti, JJ1
Zainal, N1
Carmichael, DJ1
Griffiths, JW1
Besterman, EM1
Kidner, PH1
Gillham, AD1
Summers, GD1
Siklos, P1
Chalmers, TM1
Evans, DW1
Landmark, K1
Storstein, O1
Green, AG1
Washington, HG1
Ward, DE2
Camm, AJ2
Oshrain, C1
Vismara, LA2
Vera, Z1
Miller, RR1
Mason, DT2
Benditt, DG1
Pritchett, EL1
Wallace, AG2
Koch-Weser, J1
Forester, D1
Fox, K1
Evans, T1
Rowland, E1
Krikler, D1
Dibble, JB1
Webster, NR1
Cumming, AD1
Robertson, C1
Holt, DW1
Walsh, AC1
Curry, PV1
Tynan, M1
Chan, W1
Mason, JW1
Winkle, RA1
Farshidi, A1
Spielman, SR2
Michelson, EL1
Greenspan, AM2
Meltzer, RS1
Robert, EW1
McMorrow, M1
Martin, RP1
LaBarre, A1
Strauss, HC1
Evans, GT1
Bashore, T1
Tiedeman, JS1
Jutzy, RV1
Pugh, DM1
Harner, RH1
Boyd, RB1
Deano, DA1
Mautner, RK1
Sherman, RH1
Ehsani, AI1
Haworth, E1
Burroughs, AK1
Hulting, J1
Rosenhamer, G1
Rangno, RE1
Warnica, W1
Ogilvie, RI1
Kreeft, J1
Bridger, E1
Smith, WS1
Berman, R1
Cook, WR1
He, ZS1
Komori, S1
Tamura, K1
Hashimoto, K1
Ohe, T2
Takagaki, K1
Shimomura, K2
Griffith, MJ1
Linker, NJ1
Garratt, CJ1
Waldo, AL1
Fisher, JD3
Duncan, WJ1
Tyrrell, MJ1
Bharadwaj, BB1
Suzuki, K2
Korsukewitz, J1
Wegscheider, K1
Schmutzler, H1
Kim, SG2
Seiden, SW1
Matos, JA1
Waspe, LE1
Miura, D1
Keefe, DL1
Aizawa, Y2
Funazaki, T1
Satoh, M1
Aizawa, M1
Shibata, A2
Au, PK1
Bhandari, AK1
Bream, R1
Schreck, D1
Siddiqi, R1
Rahimtoola, SH1
Willis, PW1
Ragosta, M1
Weihl, AC1
Rosenfeld, LE1
Le Corre, P1
Gibassier, D1
Descaves, C1
Sado, P1
Daubert, JC1
Le Verge, R1
Schattner, A1
Gindin, J1
Geltner, D1
Duff, HJ2
Mitchell, LB2
Nath, CF1
Manyari, DE1
Baynton, R1
Nanimatsu, H1
Shibayama, H1
Koumatsu, A1
Inoue, T1
Maeda, T1
Saikawa, T2
Ito, S2
Takaki, R2
Tsunematsu, Y1
Mercando, AD1
Tam, S1
Belhassen, B1
Pines, A1
Laniado, S1
Goedel-Meinen, L1
Hofmann, M1
Schmidt, G1
Barthel, P1
Baedeker, W1
Blömer, H1
Whitford, EG1
McGovern, B1
Schoenfeld, MH1
Garan, H1
Newell, JB1
McElroy, M1
Ruskin, JN1
Berry, NS1
Bauman, JL1
Gallastegui, JL1
Bauma, W1
Beckman, KJ1
Hariman, RJ1
Niwa, H1
Nakamura, S1
Takakura, T1
Nakagawa, M1
Fukuoka, Y1
Tamura, M1
Yonemochi, H1
Miyajima, S1
Matsuoka, A1
Okabe, M1
Rizos, I1
Lengfelder, W1
Schmitt, C1
von Olshausen, K1
Yamamoto, K1
Ikeda, K1
Kamakura, S1
Matsuhisa, M1
Sethi, KK1
Mohan, JC1
Singhal, A1
Gupta, MP1
Poole, JE1
Werner, JA1
Bardy, GH1
Graham, EL1
Pulaski, WP1
Fahrenbruch, CE1
Greene, HL1
Yasuda, M1
Toda, I1
Akioka, K1
Teragaki, M1
Oku, H1
Takeuchi, K1
Takeda, T1
Inoue, E1
Ikuno, Y1
Horiguchi, T1
Cantelli, I1
Bertaccini, P1
Ambrosioni, E1
Teichman, S1
Lisin, N1
Andriange, M1
Vandenbosch, R1
Carlier, J1
Yen, CH1
Lowrie, HS1
Dean, RR1
Amsterdam, EA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Non-invasive Programmed Stimulation to Identify High-risk Patients With Implanted Cardioverter-defibrillator[NCT02373306]150 participants (Anticipated)Interventional2013-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

10 reviews available for disopyramide and Tachyarrhythmia

ArticleYear
Antiarrhythmic drug therapy during pregnancy.
    Annals of internal medicine, 1983, Volume: 98, Issue:4

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Digitalis

1983
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
    Herz, 1983, Volume: 8, Issue:3

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atr

1983
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Heart & lung : the journal of critical care, 1984, Volume: 13, Issue:6

    Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetami

1984
[Medical treatment of extrasystole and tachycardia (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1980, Jan-18, Volume: 122, Issue:3

    Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardi

1980
[Control of recurrent ventricular tachycardia in a case of mitral valve prolapse and arterial hypertension, using the combination of disopyramide and amiodarone].
    La Clinica terapeutica, 1982, Jun-15, Volume: 101, Issue:5

    Topics: Amiodarone; Benzofurans; Disopyramide; Drug Therapy, Combination; Female; Heart Ventricles; Humans;

1982
Disopyramide.
    Annals of internal medicine, 1982, Volume: 96, Issue:3

    Topics: Arrhythmias, Cardiac; Disopyramide; Drug Interactions; Electrophysiology; Heart; Heart Block; Humans

1982
Intravenous antiarrhythmic drugs: newer aspects of therapy.
    Angiology, 1982, Volume: 33, Issue:4

    Topics: Anti-Arrhythmia Agents; Disopyramide; Electrocardiography; Hemodynamics; Humans; Injections, Intrave

1982
The treatment of ventricular rhythm disturbances.
    American heart journal, 1986, Volume: 111, Issue:6

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premat

1986
Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Pacing and clinical electrophysiology : PACE, 1986, Volume: 9, Issue:4

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic;

1986
The clinical scope of disopyramide seven years after introduction--an overview.
    Angiology, 1987, Volume: 38, Issue:2 Pt 2

    Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Heart Ventricles; Humans; Tachyc

1987

Trials

24 trials available for disopyramide and Tachyarrhythmia

ArticleYear
[Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
    Deutsche medizinische Wochenschrift (1946), 1983, Nov-04, Volume: 108, Issue:44

    Topics: Adult; Aged; Amiodarone; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Long-Term Care; Mexi

1983
[Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone].
    Archives des maladies du coeur et des vaisseaux, 1984, Volume: 77, Issue:7

    Topics: Adult; Aged; Amiodarone; Benzofurans; Clinical Trials as Topic; Disopyramide; Drug Therapy, Combinat

1984
Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia.
    European heart journal, 1980, Volume: 1, Issue:1

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Coronary

1980
[A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
    Archives des maladies du coeur et des vaisseaux, 1998, Volume: 91, Issue:12

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Double-Blind Method; Female; Humans

1998
Clinical studies of Norpace (Part XI).
    Angiology, 1975, Volume: 26, Issue:1 Pt 2

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic

1975
[Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Archives des maladies du coeur et des vaisseaux, 1976, Volume: 69, Issue:4

    Topics: Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Dr

1976
[Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Zeitschrift fur Kardiologie, 1976, Volume: 65, Issue:8

    Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Cardiac Complexes, Premature; Disopyramide; Electrocar

1976
Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Lancet (London, England), 1977, Oct-29, Volume: 2, Issue:8044

    Topics: Acute Disease; Administration, Oral; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyram

1977
Clinical studies of Norpace (Part IX).
    Angiology, 1975, Volume: 26, Issue:1 Pt 2

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Diarrhea; Disopyramide; Drug

1975
Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia.
    The American journal of cardiology, 1977, Volume: 39, Issue:7

    Topics: Aged; Clinical Trials as Topic; Coronary Disease; Disopyramide; Drug Evaluation; Heart Failure; Huma

1977
Clinical studies of Norpace (Part IV).
    Angiology, 1975, Volume: 26, Issue:1 Pt 2

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as T

1975
Clinical studies of Norpace (Part VI).
    Angiology, 1975, Volume: 26, Issue:1 Pt 2

    Topics: Adult; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Bradycardia; Clinical Trials as

1975
Clinical studies of Norpace (Part I).
    Angiology, 1975, Volume: 26, Issue:1 Pt 2

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Capsules; Clinical Trials as Top

1975
Clinical studies of Norpace (Part VII).
    Angiology, 1975, Volume: 26, Issue:1 Pt 2

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Drug Evaluatio

1975
Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
    Lancet (London, England), 1990, Sep-15, Volume: 336, Issue:8716

    Topics: Adenosine; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Disopyramid

1990
Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: patient selection and initial outcome.
    American heart journal, 1991, Volume: 121, Issue:5

    Topics: Arrhythmias, Cardiac; Data Collection; Delayed-Action Preparations; Disopyramide; Drug Therapy, Comb

1991
[Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents].
    Deutsche medizinische Wochenschrift (1946), 1985, Jul-12, Volume: 110, Issue:28-29

    Topics: Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide;

1985
Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
    Journal of the American College of Cardiology, 1985, Volume: 6, Issue:3

    Topics: Aged; Ambulatory Care; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artific

1985
Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Pacing and clinical electrophysiology : PACE, 1986, Volume: 9, Issue:4

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic;

1986
Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:12

    Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Disopyramide; Double-Blind Method;

1989
[Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Herz, 1988, Volume: 13, Issue:3

    Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Disopyr

1988
Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    American heart journal, 1985, Volume: 109, Issue:4

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; D

1985
The anticholinergic side effects of disopyramide and controlled-release disopyramide.
    Angiology, 1985, Volume: 36, Issue:11

    Topics: Delayed-Action Preparations; Disopyramide; Drug Interactions; Drug Therapy, Combination; Humans; Pyr

1985
Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug.
    Clinical pharmacology and therapeutics, 1974, Volume: 16, Issue:2

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzothiadiazines; Digoxin; Disopyramide;

1974

Other Studies

108 other studies available for disopyramide and Tachyarrhythmia

ArticleYear
New directions in antiarrhythmic drug therapy.
    The American journal of cardiology, 1984, Aug-13, Volume: 54, Issue:4

    Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benz

1984
Disopyramide-induced ventricular tachycardia.
    Archives of internal medicine, 1980, Volume: 140, Issue:3

    Topics: Alcoholism; Cardiac Complexes, Premature; Cardiomyopathies; Coronary Disease; Disopyramide; Heart Fa

1980
Ventricular tachycardia initiated by both normally and aberrantly conducted atrial premature beats.
    Pacing and clinical electrophysiology : PACE, 1980, Volume: 3, Issue:5

    Topics: Aged; Arrhythmias, Cardiac; Bundle-Branch Block; Cardiac Complexes, Premature; Cardiac Pacing, Artif

1980
Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    European journal of clinical pharmacology, 1981, Volume: 19, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; C

1981
[Anti-arrhythmic effectiveness of ethmozine, cordaron and rhythmodan in treating ischemic heart disease].
    Kardiologiia, 1981, Volume: 21, Issue:9

    Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Cardiac Complexes

1981
Treatment of chronic ventricular dysrhythmias in the young.
    Pacing and clinical electrophysiology : PACE, 1981, Volume: 4, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child,

1981
[Drug therapy of arrhythmia in coronary cardiopathy].
    La Clinica terapeutica, 1983, Apr-15, Volume: 105, Issue:1

    Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp

1983
Failure to pace following high dose antiarrhythmic therapy--reversal with isoproterenol.
    Pacing and clinical electrophysiology : PACE, 1984, Volume: 7, Issue:2

    Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electrocardiography; Hu

1984
Long-term management of arrhythmogenic right ventricular dysplasia.
    Canadian Medical Association journal, 1983, Feb-15, Volume: 128, Issue:4

    Topics: Adolescent; Cardiomegaly; Cardiomyopathies; Disopyramide; Electrocardiography; Heart Ventricles; Hum

1983
Hypoglycemic effect of disopyramide in a case of diabetes mellitus under insulin treatment.
    Acta medica Okayama, 1980, Volume: 34, Issue:4

    Topics: Adult; Diabetes Complications; Diabetes Mellitus; Disopyramide; Humans; Hypoglycemia; Insulin; Male;

1980
[A case of atypical ventricular tachycardia induced by disopyramide].
    Kokyu to junkan. Respiration & circulation, 1984, Volume: 32, Issue:4

    Topics: Disopyramide; Heart Block; Humans; Male; Tachycardia

1984
[Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
    Giornale italiano di cardiologia, 1984, Volume: 14, Issue:5

    Topics: Anti-Arrhythmia Agents; Disopyramide; Drug Evaluation; Heart Ventricles; Humans; Propafenone; Propio

1984
Ocular side effects of disopyramide.
    The British journal of ophthalmology, 1984, Volume: 68, Issue:12

    Topics: Accommodation, Ocular; Adolescent; Disopyramide; Eye Diseases; Female; Humans; Paralysis; Pupil; Tac

1984
[Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Giornale italiano di cardiologia, 1984, Volume: 14, Issue:9

    Topics: Adult; Aged; Amiodarone; Death, Sudden; Disopyramide; Drug Therapy, Combination; Electrocardiography

1984
The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    The New Zealand medical journal, 1984, Mar-14, Volume: 97, Issue:751

    Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Disopyramide; Dr

1984
Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase.
    The American journal of cardiology, 1984, Jun-01, Volume: 53, Issue:11

    Topics: Animals; Cardiac Pacing, Artificial; Disopyramide; Dogs; Electrocardiography; Electrodes; Infusions,

1984
Corrected data on disopyramide phosphate (Norpace)
    Geriatrics, 1981, Volume: 36, Issue:7

    Topics: Disopyramide; Drug Labeling; Humans; Organophosphorus Compounds; Pyridines; Tachycardia

1981
[Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
    Kokyu to junkan. Respiration & circulation, 1981, Volume: 29, Issue:2

    Topics: Administration, Oral; Adolescent; Cardiac Pacing, Artificial; Disopyramide; Electric Stimulation; Hu

1981
Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms.
    American heart journal, 1982, Volume: 103, Issue:2

    Topics: Adult; Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Cardiac Catheterization; Disop

1982
Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.
    Circulation, 1982, Volume: 65, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Atrial Fibrillation; Disopyramide; Electrocardiography; Fem

1982
Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction.
    Circulation, 1982, Volume: 66, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Atrioventricular Node; Disopyramide; Female; Heart Co

1982
Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
    Japanese circulation journal, 1983, Volume: 47, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Electrocardiogr

1983
The usefulness of Holter monitoring in the evaluation of antiarrhythmic drug efficacy for tachycardia.
    Japanese circulation journal, 1983, Volume: 47, Issue:1

    Topics: Adult; Aged; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Diltiazem; Disopyramide; Female; Hear

1983
Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
    Japanese circulation journal, 1983, Volume: 47, Issue:1

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Disopyramide; El

1983
Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
    The American journal of cardiology, 1983, Mar-01, Volume: 51, Issue:5

    Topics: Adult; Aged; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Heart Ventricles

1983
Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
    British heart journal, 1983, Volume: 49, Issue:3

    Topics: Adult; Aged; Cardiac Pacing, Artificial; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged

1983
Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.
    American heart journal, 1983, Volume: 105, Issue:5

    Topics: Aged; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Pyridines; Tachycardia

1983
The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Circulation, 1983, Volume: 67, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Ther

1983
[A case of ventricular tachycardia with non-ischemic apical aneurysm].
    Kokyu to junkan. Respiration & circulation, 1983, Volume: 31, Issue:2

    Topics: Adult; Disopyramide; Female; Heart Aneurysm; Heart Ventricles; Humans; Propranolol; Tachycardia

1983
[The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome].
    Herz, 1983, Volume: 8, Issue:3

    Topics: Anti-Arrhythmia Agents; Bundle of His; Digitalis Glycosides; Disopyramide; Electrocardiography; Huma

1983
Disopyramide induced atypical ventricular tachycardia.
    Australian and New Zealand journal of medicine, 1980, Volume: 10, Issue:6

    Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart V

1980
Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
    Chest, 1982, Volume: 81, Issue:3

    Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Disopyramide; Dose-Response Relationship, Drug;

1982
Torsade de pointes.
    Circulation, 1982, Volume: 66, Issue:1

    Topics: Aged; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Tachycardia

1982
Sustained macroreentrant ventricular tachycardia.
    American heart journal, 1982, Volume: 104, Issue:1

    Topics: Aged; Amiodarone; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Male; Procaina

1982
Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia.
    American heart journal, 1982, Volume: 104, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Ele

1982
[Atypical ventricular tachycardia due to disopyramide].
    Harefuah, 1982, Mar-15, Volume: 102, Issue:6

    Topics: Aged; Disopyramide; Female; Humans; Isoproterenol; Pyridines; Quinidine; Tachycardia

1982
Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1981, Jun-06, Volume: 59, Issue:24

    Topics: Aged; Disopyramide; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male;

1981
Disopyramide-induced Torsade de Pointes.
    Archives of internal medicine, 1981, Volume: 141, Issue:7

    Topics: Aged; Disopyramide; Female; Humans; Isoproterenol; Middle Aged; Pyridines; Tachycardia

1981
Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
    Journal of electrocardiology, 1981, Volume: 14, Issue:3

    Topics: Aged; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Middle Aged; Pyridines; Q

1981
Ventricular pacing in atypical ventricular tachycardia.
    Journal of electrocardiology, 1981, Volume: 14, Issue:2

    Topics: Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; H

1981
Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
    Circulation, 1981, Volume: 64, Issue:6

    Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Electrocardiography; Female; Heart Ve

1981
Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation.
    Japanese circulation journal, 1981, Volume: 45, Issue:10

    Topics: Adolescent; Adult; Atrioventricular Node; Disopyramide; Drug Synergism; Female; Heart Conduction Sys

1981
[Ventricular fibrillation during disopyramide treatment].
    Lakartidningen, 1981, Oct-07, Volume: 78, Issue:41

    Topics: Aged; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Aged; Pyridines; Tachycardia;

1981
Unusual dosage of disopyramide.
    The Medical journal of Australia, 1981, Oct-31, Volume: 2, Issue:9

    Topics: Disopyramide; Humans; Injections, Intravenous; Male; Middle Aged; Pyridines; Tachycardia

1981
"Torsade de pointes" - A unique ventricular arrhythmia report of eight cases and review of the literature.
    Singapore medical journal, 1981, Volume: 22, Issue:4

    Topics: Aged; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Ag

1981
[Pharmacological therapy and prevention of recurrent ventricular tachycardia].
    Giornale italiano di cardiologia, 1981, Volume: 11, Issue:11

    Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Bunaftine; Disopyramide; Humans; Male; Middle Aged;

1981
Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia.
    The American journal of cardiology, 1980, Volume: 45, Issue:3

    Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Fe

1980
Prolonged QT interval, atrioventricular block, and torsade de pointes after antiarrhythmic therapy.
    British medical journal, 1980, Mar-29, Volume: 280, Issue:6218

    Topics: Aged; Disopyramide; Electrocardiography; Female; Heart; Heart Block; Humans; Lidocaine; Pyridines; T

1980
Respiratory difficulty after use of disopyramide.
    The New England journal of medicine, 1980, Sep-04, Volume: 303, Issue:10

    Topics: Disopyramide; Drug Hypersensitivity; Heart Ventricles; Humans; Male; Middle Aged; Pyridines; Respira

1980
Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, Sep-13, Volume: 58, Issue:11

    Topics: Administration, Oral; Disopyramide; Electrocardiography; Female; Humans; Middle Aged; Pyridines; Tac

1980
Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.
    British medical journal, 1980, Jul-19, Volume: 281, Issue:6234

    Topics: Aged; Arrhythmias, Cardiac; Atrioventricular Node; Digitalis Glycosides; Disopyramide; Female; Heart

1980
[Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
    Schweizerische medizinische Wochenschrift, 1980, Jun-14, Volume: 110, Issue:24

    Topics: Adult; Disopyramide; Female; Heart Ventricles; Humans; Male; Middle Aged; Pyridines; Tachycardia

1980
Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of tetralogy of fallot.
    The American journal of cardiology, 1980, Volume: 46, Issue:3

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Child; Disopyramide; Electrocardiogr

1980
Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction.
    The American journal of cardiology, 1980, Volume: 46, Issue:5

    Topics: Animals; Arrhythmias, Cardiac; Disopyramide; Dogs; Electrophysiology; Heart Conduction System; Heart

1980
Extreme tachycardia complicating the use of disopyramide in atrial flutter.
    British heart journal, 1980, Volume: 44, Issue:5

    Topics: Atrial Flutter; Disopyramide; Humans; Male; Middle Aged; Pyridines; Tachycardia

1980
[Paradoxic response to disopyramide and quinidine (author's transl)].
    Zeitschrift fur Kardiologie, 1980, Volume: 69, Issue:8

    Topics: Adult; Aged; Disopyramide; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Py

1980
[Drug therapy of tachyarrhythmias (author's transl)].
    Klinische Wochenschrift, 1978, Feb-15, Volume: 56, Issue:4

    Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprind

1978
The treatment of supraventricular arrhythmias.
    British journal of hospital medicine, 1979, Volume: 21, Issue:4

    Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt

1979
Clinical studies of Norpace (Part X).
    Angiology, 1975, Volume: 26, Issue:1 Pt 2

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes

1975
Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    British heart journal, 1975, Volume: 37, Issue:8

    Topics: Adolescent; Adult; Atrial Fibrillation; Atrioventricular Node; Cardiac Complexes, Premature; Child;

1975
Ventricular tachycardia after disopyramide.
    Lancet (London, England), 1978, Jan-14, Volume: 1, Issue:8055

    Topics: Disopyramide; Humans; Middle Aged; Pyridines; Tachycardia

1978
Ectopic atrial tachycardia on swallowing. Report on favourable effect of verapamil.
    Acta medica Scandinavica, 1979, Volume: 205, Issue:3

    Topics: Atrioventricular Node; Atropine; Cardiac Complexes, Premature; Deglutition; Disopyramide; Edrophoniu

1979
Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
    Scottish medical journal, 1979, Volume: 24, Issue:1

    Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Female; Humans; Lidocaine; Male; M

1979
Atrial bigeminy with block associated with bradycardia and paroxysmal atrial fibrillation -- an important variant of the tachycardia-bradycardia syndrome.
    Clinical cardiology, 1979, Volume: 2, Issue:2

    Topics: Adult; Aged; Atrial Fibrillation; Bradycardia; Cardiac Complexes, Premature; Disopyramide; Electroca

1979
Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
    European journal of cardiology, 1979, Volume: 9, Issue:4

    Topics: Administration, Oral; Adult; Aged; Disopyramide; Electric Stimulation; Female; Follow-Up Studies; He

1979
Disopyramide.
    The New England journal of medicine, 1979, Apr-26, Volume: 300, Issue:17

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Disopyramide; Heart; He

1979
Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
    Chest, 1979, Volume: 75, Issue:6

    Topics: Administration, Oral; Atrial Fibrillation; Disopyramide; Humans; Injections, Intravenous; Lidocaine;

1979
'Bradycardia-tachycardia' syndrome 8 yr after correction of Fallot's tetralogy.
    European journal of cardiology, 1979, Volume: 10, Issue:2

    Topics: Adolescent; Arrhythmias, Cardiac; Atrial Flutter; Bradycardia; Child; Child, Preschool; Death, Sudde

1979
Adverse reaction to disopyramide.
    Postgraduate medical journal, 1979, Volume: 55, Issue:646

    Topics: Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Humans; Hypotension; Injections, In

1979
Interaction between disopyramide and practolol.
    British medical journal, 1979, Nov-17, Volume: 2, Issue:6200

    Topics: Aged; Disopyramide; Drug Interactions; Humans; Male; Middle Aged; Practolol; Pyridines; Tachycardia

1979
Paediatric use of mexiletine and disopyramide.
    British medical journal, 1979, Dec-08, Volume: 2, Issue:6203

    Topics: Disopyramide; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Male; Mexiletine;

1979
Disopyramide for cardiac arrhythmias in children.
    The Medical journal of Australia, 1978, Apr-08, Volume: 1, Issue:7

    Topics: Child; Disopyramide; Female; Humans; Pyridines; Tachycardia

1978
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Circulation, 1978, Volume: 58, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D

1978
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Circulation, 1978, Volume: 58, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; D

1978
Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    The American journal of cardiology, 1978, Volume: 42, Issue:6

    Topics: Administration, Oral; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Heart C

1978
Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction.
    Circulation, 1979, Volume: 59, Issue:2

    Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular Node; Bradycardia; Cardiac

1979
Resistant ventricular tachycardias and recurrent cardiac arrests. 96 episodes.
    Chest, 1977, Volume: 71, Issue:3

    Topics: Aged; Disopyramide; Electric Countershock; Heart Aneurysm; Humans; Male; Myocardial Infarction; Prop

1977
The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Chest, 1977, Volume: 71, Issue:5

    Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Disopy

1977
Disopyramide and warfarin interaction.
    British medical journal, 1977, Oct-01, Volume: 2, Issue:6091

    Topics: Disopyramide; Drug Interactions; Humans; Male; Middle Aged; Pyridines; Tachycardia; Warfarin

1977
Disopyramide in ventricular tachycardia.
    Acta medica Scandinavica, 1976, Volume: 200, Issue:3

    Topics: Blood Pressure; Cardiac Output; Disopyramide; Electrocardiography; Heart Rate; Heart Ventricles; Hum

1976
The effects of disopyramide on the human heart: an electrophysiological study.
    The Journal of international medical research, 1976, Volume: 4, Issue:1 Suppl

    Topics: Adolescent; Adult; Child; Disopyramide; Electrocardiography; Female; Heart; Heart Conduction System;

1976
Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.
    The Journal of international medical research, 1976, Volume: 4, Issue:1 Suppl

    Topics: Adult; Aged; Disopyramide; Drug Administration Schedule; Female; Heart Ventricles; Humans; Infusions

1976
Clinical studies of Norpace (Part V).
    Angiology, 1975, Volume: 26, Issue:1 Pt 2

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Female; Hu

1975
Inhibitory effect of moricizine on reperfusion induced tachyarrhythmias in rats--a comparison study with disopyramide and mexiletine.
    Japanese circulation journal, 1992, Volume: 56, Issue:8

    Topics: Animals; Disopyramide; Heart; Hemodynamics; Male; Mexiletine; Moricizine; Myocardial Infarction; Rat

1992
Repetitive nonsustained monomorphic ventricular tachycardia aborted by methoxamine and sleep "heart rate dependent ventricular tachycardia".
    Pacing and clinical electrophysiology : PACE, 1991, Volume: 14, Issue:10

    Topics: Adult; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Electrocoagulation; Heart Rate

1991
Disopyramide as a negative inotrope in obstructive cardiomyopathy in children.
    The Canadian journal of cardiology, 1991, Volume: 7, Issue:2

    Topics: Cardiomyopathy, Hypertrophic; Carnitine; Child; Disopyramide; Ductus Arteriosus, Patent; Echocardiog

1991
Clinical features of sustained ventricular tachycardia among various underlying heart diseases.
    The Tohoku journal of experimental medicine, 1990, Volume: 162, Issue:1

    Topics: Adult; Disopyramide; Electroencephalography; Heart Diseases; Heart Rate; Heart Ventricles; Hemodynam

1990
Periodic changes in cycle length of ventricular tachycardia: a Wenckebach type exit block?
    Journal of electrocardiology, 1986, Volume: 19, Issue:4

    Topics: Bundle of His; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Disopyramide; Electrocardio

1986
Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Journal of the American College of Cardiology, 1987, Volume: 9, Issue:2

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Disop

1987
Potentially fatal interaction between erythromycin and disopyramide.
    The American journal of medicine, 1989, Volume: 86, Issue:4

    Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Drug Inte

1989
Fatal torsade de pointes following jaundice in a patient treated with disopyramide.
    Postgraduate medical journal, 1989, Volume: 65, Issue:763

    Topics: Disopyramide; Female; Humans; Jaundice; Liver; Middle Aged; Tachycardia

1989
Concentration-response relationships of disopyramide in patients with ventricular tachycardia.
    Clinical pharmacology and therapeutics, 1989, Volume: 45, Issue:5

    Topics: Disopyramide; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Female; H

1989
[Three cases of Torsades de pointes].
    Kokyu to junkan. Respiration & circulation, 1989, Volume: 37, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Disopyramide; Electrocardiography; Female; Humans; Hypokalemia; Male

1989
Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Journal of the American College of Cardiology, 1989, Mar-01, Volume: 13, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Disopyramide; Drug Therapy, Combination; Elect

1989
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
    Chest, 1989, Volume: 95, Issue:4

    Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combina

1989
Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    American heart journal, 1988, Volume: 115, Issue:2

    Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Female;

1988
Analysis of antiarrhythmic drug concentrations determined during electrophysiologic drug testing in patients with inducible tachycardias.
    The American journal of cardiology, 1988, Apr-15, Volume: 61, Issue:11

    Topics: Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Electrophysiology; Humans; Procainamide;

1988
A case of arrhythmogenic right ventricular dysplasia with prominent late potential.
    Japanese heart journal, 1988, Volume: 29, Issue:1

    Topics: Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Heart Vent

1988
Danger of use of disopyramide in patients with hypertrophic obstructive cardiomyopathy. An electrophysiologic study.
    Japanese heart journal, 1988, Volume: 29, Issue:1

    Topics: Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Disopyramide; Drug Evaluation; Electrocard

1988
Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
    Journal of the American College of Cardiology, 1987, Volume: 9, Issue:4

    Topics: Adult; Aged; Disopyramide; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Ma

1987
Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    European heart journal, 1987, Volume: 8, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Coronary Disease; Disopyramide; Electroc

1987
[Electrophysiological studies in 2 patients with chronic persistent atrial tachycardia].
    Kokyu to junkan. Respiration & circulation, 1987, Volume: 35, Issue:7

    Topics: Adult; Disopyramide; Electrocardiography; Electrophysiology; Female; Humans; Lidocaine; Middle Aged;

1987
Electromechanical dissociation induced by intravenous disopyramide.
    The Journal of the Association of Physicians of India, 1987, Volume: 35, Issue:8

    Topics: Adolescent; Disopyramide; Female; Heart Arrest; Humans; Infusions, Intravenous; Pulmonary Edema; Tac

1987
Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    American heart journal, 1986, Volume: 112, Issue:2

    Topics: Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophy

1986
[Three cases of torsades de pointes due to anti-arrhythmic agents].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1986, Volume: 75, Issue:9

    Topics: Aged; Aged, 80 and over; Disopyramide; Electrocardiography; Female; Humans; Middle Aged; Procainamid

1986
[Treatment of disturbances of cardiac rhythm using intravenous disopyramide].
    Revue medicale de Liege, 1974, May-01, Volume: 29, Issue:9

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brad

1974
[Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)].
    Acta cardiologica, 1974, Volume: Suppl 18

    Topics: Administration, Oral; Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Cardiac Complexe

1974
Compounds related to 4-disopropylamino-2-phenyl-2(2-pyridyl)butyramide. Their synthesis and antiarrhythmic activity.
    Journal of medicinal chemistry, 1974, Volume: 17, Issue:11

    Topics: Animals; Anti-Arrhythmia Agents; Coronary Vessels; Disopyramide; Dogs; Heart Rate; Ligation; Ouabain

1974